Hardy Diagnostics

Hardy Diagnostics, a self-certified small disadvantaged business headquartered in Santa Maria, California, supplies microbiological testing materials, culture media, reagents, diagnostic products, and laboratory equipment to federal civilian health and food-safety agencies as a prime contractor operating predominantly under full-and-open competition rather than set-asides. The vendor is a for-profit Subchapter S corporation registered in SAM.gov since 2002 and competes across NAICS codes centered on in-vitro diagnostic substance manufacturing, biological product manufacturing, and testing laboratory services, with the bulk of recent awards falling under PSC Laboratory Equipment and Supplies and In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.

Hardy Diagnostics maintains an established footprint with four named indefinite delivery vehicles totaling approximately $3.6 million in ceiling value. The anchor vehicle is a $2.3 million Indefinite Delivery contract with the Department of Agriculture's Food Safety and Inspection Service (awarded June 2, 2022, extending through June 12, 2027) for 400-milliliter Neutralizing Buffered Peptone Water (NBPW) supplied to Eastern, Western, and Midwestern U.S. laboratories under a total small business set-aside designation. Delivery orders against this IDIQ range from $3,057.50 to $233,863.72; a $108,638.20 delivery order issued September 1, 2026, supplies 400 milliliters of NBPW to three Office of Public Health laboratories with completion by March 31, 2027. Hardy Diagnostics also holds a $840,000 single-award Blanket Purchase Agreement with the Department of Health and Human Services Indian Health Service (established June 20, 2023, extending through June 20, 2028) for laboratory consumables, reagents, media, and test kits supporting clinical diagnostics at the Phoenix Indian Medical Center, Whiteriver Service Unit, and Chinle locations; four task orders against this BPA have totaled $403,156.13 as of August 2025, including a $37,000 call issued February 4, 2026, to support the Whiteriver Service Unit. Hardy Diagnostics holds a $500,000 Federal Supply Schedule contract with the General Services Administration's Federal Acquisition Service (awarded July 25, 2022, extending through July 24, 2027) for laboratory equipment and maintenance services under Special Item Numbers 339113LAB and 532490L, with recent ordering activity including delivery orders from the Bureau of Medicine and Surgery for microbiology media and blood agar plates. A newer $185,000 IHS BPA was awarded February 3, 2026, extending through January 14, 2031.

Customer concentration sits heavily with civilian health and food-safety agencies. The top five customers by award count and combined potential value account for 21% of recent awards and 82% of combined potential value. The Department of Agriculture's FSIS Office of Administrative Services Procurement Management Branch leads by dollar value (33 awards, $6.6 million combined potential value), followed by the Department of Health and Human Services Indian Health Service (224 awards, $4.1 million combined potential value). The National Institutes of Health Clinical Center ranks third in potential value (18 awards, $1.6 million) and appears as a sole-source buyer for cGMP-compliant culture media and organism supplies; Hardy Diagnostics received a $150,000 sole-source purchase order from NIH on November 1, 2022, for cGMP sterility testing service materials and a $135,000 sole-source award on February 6, 2025, for identical supplies. The Department of Veterans Affairs Veterans Integrated Service Network 8 (2 awards, $1.3 million combined potential value) and GSA Federal Acquisition Service (2 awards, $875 thousand combined potential value) round out the top five by dollars. The Indian Health Service dominates by volume (224 awards across multiple service units and facilities), while FSIS and USDA carry the largest single-award values.

Activity has remained flat to declining over the past five years — thirteen awards in 2022 declining to six in 2026 — with five awards (combined potential value $494 thousand) reaching ultimate completion in the next twenty-four months and therefore facing recompete. The top parent vehicles are dominated by the GSA Federal Supply Schedule (193 task orders, $176 thousand combined potential value) and multiple Indian Health Service BPAs, including BPA HHSI248201300017B (44 task orders), BPA HHSI248200510016B (41 task orders), and BPA HHSI248201300040B (41 task orders, $37 thousand combined potential value). Hardy Diagnostics operates exclusively as a prime contractor across its federal footprint; the source records no subcontract awards. The vendor's award portfolio spans 1,590 total awards with $17.6 million in combined potential value and $9.4 million obligated (54% of potential value), distributed across twenty-two distinct customer agencies. The in-vitro diagnostic substance manufacturing NAICS code dominates the portfolio (403 awards), with laboratory equipment and supplies capturing 814 awards under top PSC codes and in-vitro diagnostic substances, reagents, test kits and sets accounting for 463 awards. Recent award activity emphasizes recurring delivery of NBPW and specialized culture media in support of federal food-safety inspection, clinical diagnostics, and healthcare operations.